USSPX
Price
$79.84
Change
+$0.60 (+0.76%)
Updated
Aug 8 closing price
Net Assets
13.72B
VSTSX
Price
$300.02
Change
+$1.99 (+0.67%)
Updated
Aug 8 closing price
Net Assets
1.91T
Interact to see
Advertisement

USSPX vs VSTSX

Header iconUSSPX vs VSTSX Comparison
Open Charts USSPX vs VSTSXBanner chart's image
Victory 500 Index Member
Price$79.84
Change+$0.60 (+0.76%)
VolumeN/A
Net Assets13.72B
Vanguard Total Stock Mkt Idx Instl Sel
Price$300.02
Change+$1.99 (+0.67%)
VolumeN/A
Net Assets1.91T
USSPX vs VSTSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
USSPX vs. VSTSX commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is USSPX is a Buy and VSTSX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 1.91T vs. USSPX (13.7B). VSTSX pays higher dividends than USSPX: VSTSX (1.20) vs USSPX (0.93). USSPX was incepted earlier than VSTSX: USSPX (29 years) vs VSTSX (9 years). USSPX (0.24) is less costly to investors than VSTSX (0.01). USSPX is a more actively managed with annual turnover of: 5.00 vs. VSTSX (2.00). USSPX has a lower initial minimum investment than VSTSX: USSPX (3000) vs VSTSX (5000000000). VSTSX (19.70) and USSPX (19.29) have marching annual gain over last year. VSTSX (85.11) and USSPX (82.72) have equivalent 5 years return.
USSPXVSTSXUSSPX / VSTSX
Total Expense Ratio0.240.012,400%
Annual Report Gross Expense Ratio0.240.012,400%
Fund Existence29 years9 years-
Gain YTD9.5528.088118%
Front LoadN/AN/A-
Min. Initial Investment300050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets13.7B1.91T1%
Annual Yield % from dividends0.931.2077%
Returns for 1 year19.2919.7098%
Returns for 3 years54.6952.05105%
Returns for 5 years82.7285.1197%
Returns for 10 years191.84N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AACT11.400.01
+0.09%
Ares Acquisition Corp
MOLN3.66N/A
N/A
Molecular Partners AG
IEX158.26-0.27
-0.17%
IDEX Corp
LYRA6.70-0.19
-2.76%
Lyra Therapeutics Inc
HCM15.00-1.31
-8.03%
HUTCHMED (China) Limited